Although trametinib-treated AsPC-1(Vector) xenografts (V + T) impaired tumor growth, its effect was not stronger than in AsPC-1(STAT3-shRNA) xenografts (S + T) mice (Figure 8A and 8B). This evidence concerns the gene STAT3 and neoplasm.